| Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection HK Okur, K Yalcin, C Tastan, S Demir, B Yurtsever, GS Karakus, ... New microbes and new infections 37, 100756, 2020 | 47 | 2020 |
| SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients C Taştan, B Yurtsever, G KARAKUŞ, DDİ KanÇaĞi, S Demir, S Abanuz, ... Turkish Journal of Biology 44 (7), 192-202, 2020 | 32 | 2020 |
| Anti-cancer effect of metformin on the metastasis and invasion of primary breast cancer cells through mediating NF-kB activity G Yenmis, EY Sarac, N Besli, T Soydas, C Tastan, DD Kancagi, M Yilanci, ... Acta Histochemica 123 (4), 151709, 2021 | 29 | 2021 |
| Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates G Sir Karakus, C Tastan, D Dilek Kancagi, B Yurtsever, G Tumentemur, ... Scientific reports 11 (1), 5804, 2021 | 16 | 2021 |
| Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61. 3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice RD Turan, C Tastan, D Dilek Kancagi, B Yurtsever, G Sir Karakus, S Ozer, ... Scientific reports 11 (1), 15799, 2021 | 12 | 2021 |
| Mutational landscape of SARS-CoV-2 genome in Turkey and impact of mutations on spike protein structure. UO Ozden Hatirnaz Ng, Sezer Akyoney, Ilayda Sahin, Huseyin Okan Soykam ... PLoS One 16 (12), e0260438, 2021 | 10 | 2021 |
| Preclinical assessment of efficacy and safety analysis of CAR-T cells (ISIKOK-19) targeting CD19-expressing B-cells for the first Turkish academic clinical trial with relapsed … C Taştan, DD Kançağı, RD Turan, B Yurtsever, D Çakırsoy, S Abanuz, ... Turkish Journal of Hematology 37 (4), 234, 2020 | 9 | 2020 |
| Preliminary report of the academic CAR-T (ISIKOK-19) cell clinical trial in Turkey: Characterization of product and outcomes of clinical application E Erdoğan, K Yalçın, C Hemşinlioğlu, A Sezgin, U Seyis, DD Kancağı, ... Turkish Journal of Hematology 39 (3), 206, 2022 | 5 | 2022 |
| microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An in Vitro Model ED Arisan, DA Dart, GH Grant, A Dalby, DD Kancagi, RD Turan, ... ACS omega 7 (42), 38003-38014, 2022 | 4 | 2022 |
| Preliminary report of preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates, SK-01 version 1 and OZG-3861 version 1 G Sir Karakus, C Tastan, DD Kancagi, B Yurtsever, G Tumentemur, ... BioRxiv, 2020.09. 04.277426, 2020 | 4 | 2020 |
| In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A C Hemşinlioğlu, ES Aslan, C Taştan, D Çakırsoy, RD Turan, U Seyis, ... Turkish Journal of Hematology 40 (2), 118, 2023 | 2 | 2023 |
| The effects of thymoquinone on pancreatic cancer and immune cells C Alandağ, DD Kancaği, G Karakuş, D Çakirsoy, E Ovali, E Karaman, ... Revista da Associação Médica Brasileira 68 (8), 1023-1026, 2022 | 2 | 2022 |
| Nükleik Asitler: İzolasyonu, Saflaştırılması, Tayini ve Hibridizasyonu (M. Karataş) DD Kançağı, İ Öğülür Moleküler Biyoloji 1, 263-273, 2012 | 2 | 2012 |
| Lentiviral Micro-dystrophin Gene Treatment into Late-stage mdx Mice for Duchenne Muscular Dystrophy Disease SA Eren, C Tastan, KB Karadeniz, RD Turan, D Cakirsoy, DD Kancagi, ... Current Gene Therapy 23 (4), 304-315, 2023 | 1 | 2023 |
| The effectiveness of ACB-IP 1.0 universal pathogen free concentrated cocktail convalescent plasma in COVID-19 infection C Hemsinlioglu, NB Pelit, K Yalcin, OS Gunaydın, NO Sahin, ES Karagacli, ... medRxiv, 2021.03. 05.21251413, 2021 | 1 | 2021 |
| Preparation of Cell-Loaded Microbeads as Stable and Injectable Delivery Platforms for Tissue Engineering MA Karaca, DD Kancagi, U Ozbek, E Ovali, O Gok Biomimetics 8 (2), 155, 2023 | | 2023 |
| Macro-Capsule Fabrication via 3D Printing for Mesenchymal Stem Cell Encapsulation MA KARACA, DD KANÇAĞI, U ÖZBEK, E OVALI, GOK Ozgul International Journal of Advances in Engineering and Pure Sciences 35 (2 …, 2023 | | 2023 |
| Türkiye Akademik CAR-T Hücre (ISIKOK-19) Klinik Çalışması Ön Raporu: Ürün Karakterizasyonu ve Klinik Uygulama Sonuçları E Erdoğan, K Yalçın, C Hemşinlioğlu, A Sezgin, U Seyis, DD Kancağı, ... Turkish Journal of Hematology 39 (3), 206-210, 2022 | | 2022 |
| SARS‐CoV‐2 Pandemisi: OZG‐3861 Serüveni… OE Dilek Kancaği, D. 9. BUHASDER Kongresi. Uluslararası katılımlı, 2021 | | 2021 |
| Türkiye'nin ilk akademik CAR-T Hücre (ISIKOK 19) Faz 1/2 Çalışma Sonuçları 47. Ulusal Hematoloji Kongresi, 2021 | | 2021 |
